KRAS and Miyoshi myopathy: Importantly, only few genes are recurrently mutated (e.g., KRas/NRas, FAM46C, TP53, BRaf, TRAF3, and DIS3) and MM driver mutations are limited by vast intra-and inter-patient genetic heterogeneity.